• Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • FP «LEKHIM» LLC
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Natural drinking water Enjoy
    • Natural drinking water Cenoman
  • PHARMACIES
  • Export
  • News
  • Contacts
Products
Back to catalog
Home / Products / Ketalgin

Ketalgin

0,01 g, № 10
Pharmacotherapeutic group
Agents affecting musculo-skeletal system
Active ingredient
Ketorolac tromethamine
Pharmaceutical form
Tablets
ATC code
M01AB15
RX/OTC
RX
Registration certificate
UA/3314/01/01

General properties

Pharmacotherapeutic group

Nonsteroidal anti-inflammatory and antirheumatic agents.

Therapeutic indications

Short-term treatment of moderate-intensity pain, including post-operative pain.

Contraindications
  • Hypersensitivity to ketorolac or other components of the drug.
  • Active peptic ulcer, recent gastrointestinal bleeding or perforation, ulcer decease or gastrointestinal bleeding in anamnesis;
  • Bronchial asthma, rhinitis, angioedema or urticaria caused by the use of acetilsalicylic acid or other nonsteroidal anti-inflammatory drugs (due to  potential of severe anaphylactic reactions);
  • Bronchial asthma in anamnesis;
  • Do not use as analgesic before and during surgery;
  • Severe heart failure;
  • A complete or partial syndrome of nasal polyps, Quincke's disease or bronchospasm;
  • do not apply to patients who have had surgery with a high risk of haemorrhage or incomplete stop of bleeding and patients who take anticoagulants,  including low doses of heparin (2500-5000 units per 12 hours);
  • moderate hepatic or severe renal insufficiency (creatinine clearance in the blood serum more than 160 mmol/L);
  • suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, including problems with blood clotting, and the high risk of bleeding;
  • Simultaneous treatment with other nonsteroidal anti-inflammatory drugs (NSAIDs) (including selective inhibitors of cyclooxygenase), acetylsalicylic acid, warfarin, pentoxifylin, probenecid or lithium salts;
  • Hypovolemia, dehydration;
  • The risk of renal failure due to reduction of the volume of liquid.

Pharmaceutical characteristics

Main physicochemical properties

Tablets of white ir almost white with yellowish tint color.

Shelf life
3 years.
Storage

Keep out of reach of children in original package under temperature not exceeding 25 °С.

Manufacturer
JSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.

 

 

 

Back to catalog
  • About company
    • Managing company “Lekhim”
    • Manufacturing site “Lekhim-Kharkiv”
    • Manufacturing site “Technolog”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • News/Events
    • Partners
  • Products
    • Browse by group of action
    • Browse alphabetically
    • Browse by active ingredient
  • Export
    • Foreign economic activity
  • Contact information
Поиск по сайту
Designed in
© 2025. Лекхим.
  • Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • FP «LEKHIM» LLC
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Natural drinking water Enjoy
    • Natural drinking water Cenoman
  • PHARMACIES
  • Export
  • News
  • Contacts
Поиск по сайту
Поиск по сайту